Clinical studies with a new podophyllotoxin derivative, epipodophyllotoxin, 4'-demethyl-9-(4,6-O-2-thenylidine- -D-glucopyranoside) (NSC-122819). (Q33467758)
scientific article
Language:
Current Data About Clinical studies with a new podophyllotoxin derivative, epipodophyllotoxin, 4'-demethyl-9-(4,6-O-2-thenylidine- -D-glucopyranoside) (NSC-122819).
(P31) (Q13442814)
(P248)
(P698) 4946082
(P813) Thursday, July 27, 2017

(P50) (Q30512486)
(P1545) 1
(P248)
(P698) 4946082
(P813) Thursday, July 27, 2017

(P304) 575-581
(P248)
(P698) 4946082
(P813) Thursday, July 27, 2017

(P433) 5
(P248)
(P698) 4946082
(P813) Thursday, July 27, 2017

(P478) 55
(P248)
(P698) 4946082
(P813) Thursday, July 27, 2017

(P577) Wednesday, December 1, 1971
(P248)
(P698) 4946082
(P813) Thursday, July 27, 2017

(P1433) (Q27710278)
(P248)
(P698) 4946082
(P813) Thursday, July 27, 2017

(P1476) "Clinical studies with a new podophyllotoxin derivative, epipodophyllotoxin, 4'-demethyl-9-(4,6-O-2-thenylidine- -D-glucopyranoside) (NSC-122819)." (language: en)
(P248)
(P698) 4946082
(P813) Thursday, July 27, 2017

(P2093) O S Selawry
(P1545) 2
(P248)
(P698) 4946082
(P813) Thursday, July 27, 2017

H H Hansen
(P1545) 3
(P248)
(P698) 4946082
(P813) Thursday, July 27, 2017

other details
description scientific article

External Links
(P698) 4946082